Crook E D, McClain D A
Department of Medicine, University of Mississippi Medical Center, Jackson 39216, USA.
Diabetes. 1996 Mar;45(3):322-7. doi: 10.2337/diab.45.3.322.
The hexosamine biosynthesis pathway has been hypothesized to be involved in mediating some of the adverse effects of high glucose. We have previously shown that glucose downregulates basal glycogen synthase (GS) activity in Rat-1 cells and that overexpressing the rate-limiting enzyme in the hexosamine biosynthesis pathway (glutamine:fructose-6-phosphate amidotransferase [GFA]) makes the cells more sensitive to these effects of glucose. GFA overexpression also leads to a reduction in insulin sensitivity of GS. Here we examine the effects of glucose and glucosamine on insulin-stimulated GS activity and on protein phosphatase-1 (PP1) activity. These activities were assayed in cytoplasmic extracts from Rat-1 fibroblasts overexpressing human GFA and cultured in varying glucose concentrations. Both maximal insulin-stimulated GS activity and insulin sensitivity decreased with increasing glucose. Overexpression of GFA leads to a further reduction in insulin sensitivity but not in maximal insulin-stimulated GS activity. Because there were no differences in total (glucose-6-phosphate-dependent) GS activity between cell lines or as a function of glucose concentration, these results most likely reflect a change in the phosphorylation state of the synthase. Activity of PP1, a potential mediator of these effects, was responsive to glucose and hexosamines. Control cells showed a 9.3 +/- 4.3% decrease in PP1 activity with increasing glucose. GFA cells showed a greater response to glucose, with PP1 activity decreasing 34.2 +/- 5.5% with increasing glucose. Glucosamine was more potent than glucose in decreasing PP1 activity in control cells. Cells overexpressing the normal human insulin receptor (HIRc-B) were used to facilitate analysis of insulin-stimulated PP1 activity. Stimulation with 1.7 mmol/l insulin led to a 37.6 +/- 9.9% increase in PP1 activity in HIRc-B cells cultured in 1 mmol/l glucose, while cells cultured in 5 mmol/l glucosamine or 20 mmol/l glucose demonstrated only 3.79 +/- 0.60 or 1.6 +/- 0.75% increases, respectively. We conclude that both basal and insulin- stimulable GS and PP1 activity are downregulated by high glucose in fibroblasts and this regulation is mediated by products of the hexosamine biosynthesis pathway.
己糖胺生物合成途径被认为参与介导高糖的一些不良反应。我们之前已经表明,葡萄糖可下调大鼠-1细胞中的基础糖原合酶(GS)活性,并且在己糖胺生物合成途径中过表达限速酶(谷氨酰胺:果糖-6-磷酸酰胺转移酶[GFA])会使细胞对葡萄糖的这些作用更加敏感。GFA过表达还会导致GS的胰岛素敏感性降低。在此,我们研究葡萄糖和氨基葡萄糖对胰岛素刺激的GS活性以及蛋白磷酸酶-1(PP1)活性的影响。在过表达人GFA并在不同葡萄糖浓度下培养的大鼠-1成纤维细胞的细胞质提取物中测定这些活性。随着葡萄糖浓度增加,最大胰岛素刺激的GS活性和胰岛素敏感性均降低。GFA过表达导致胰岛素敏感性进一步降低,但最大胰岛素刺激的GS活性未降低。由于细胞系之间或作为葡萄糖浓度函数的总(依赖于6-磷酸葡萄糖的)GS活性没有差异,这些结果很可能反映了合酶磷酸化状态的变化。PP1作为这些作用的潜在介导因子,其活性对葡萄糖和己糖胺有反应。对照细胞随着葡萄糖浓度增加,PP1活性降低9.3±4.3%。GFA细胞对葡萄糖反应更大,随着葡萄糖浓度增加,PP1活性降低34.2±5.5%。在对照细胞中,氨基葡萄糖在降低PP1活性方面比葡萄糖更有效。使用过表达正常人胰岛素受体(HIRc-B)的细胞来促进对胰岛素刺激的PP1活性的分析。用1.7 mmol/L胰岛素刺激导致在1 mmol/L葡萄糖中培养的HIRc-B细胞中PP1活性增加37.6±9.9%,而在5 mmol/L氨基葡萄糖或20 mmol/L葡萄糖中培养的细胞分别仅增加3.79±0.60%或1.6±0.75%。我们得出结论,在成纤维细胞中,基础和胰岛素刺激的GS以及PP1活性均被高糖下调,并且这种调节由己糖胺生物合成途径的产物介导。